Tools & Calculators
Stocks
F&O
Mutual Funds
Sector: Pharmaceuticals & Biotechnology
|Large Cap
J B Chemicals & Pharmaceuticals Ltd.
₹1,965.10
Invest in JBCHEPHARM with up to 2.86x margin.
Trade with MTF₹1943.50
₹1983.10
₹1494.80
₹2195.00
Markets Today
Historical Performance
Indicator | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|
| Total Revenue | 990.91 | 1,022.65 | 1,039.90 | 901.34 | 913.51 |
| Operating Expense | 721.41 | 724.29 | 746.78 | 670.36 | 668.11 |
| Operating Profit | 269.50 | 298.36 | 293.12 | 230.98 | 245.40 |
| Depreciation | 43.62 | 43.11 | 41.40 | 44.41 | 41.18 |
| Interest | 1.59 | 1.01 | 0.66 | 0.93 | 1.85 |
| Tax | 61.91 | 68.07 | 67.09 | 49.37 | 53.14 |
| Net Profit | 179.27 | 200.42 | 197.87 | 149.80 | 156.39 |
₹1965.10
↗ Bullish Moving Average
6
↘ Bearish Moving Average
10
| Held By | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 |
|---|---|---|---|---|---|---|
| Promoter | 53.7 | 53.7 | 47.8 | 47.7 | 47.6 | 47.6 |
| FII | 13.6 | 14.6 | 18.3 | 17.8 | 15.3 | 14.9 |
| DII | 16.8 | 16.4 | 18.7 | 19.6 | 22.8 | 23.3 |
| Public | 15.8 | 15.3 | 15.1 | 14.9 | 14.3 | 14.2 |
| Period | Combined Delivery Volume | NSE+BSE Traded Volume Avg | Daily Avg Delivery Volume % |
|---|---|---|---|
| Day | 4 L | 5.84 L | 68.62% |
| Week | 2.48 L | 3.97 L | 62.44% |
| 1 Month | 2.7 L | 4.23 L | 63.98% |
| 6 Month | 1.5 L | 2.47 L | 60.78% |
Benjamin Graham Value Screen
30 Day SMA crossing over 200 Day SMA, and current price greater than open
Mid-range Performer (DVM)
Companies with high TTM EPS Growth
High Momentum Scores (Technical Scores greater than 50)
Effectively using Shareholders fund - Return on equity (ROE) improving since last 2 year
Efficient in managing Assets to generate Profits - ROA improving since last 2 year
Growth in Quarterly Net Profit with increasing Profit Margin (YoY)
Companies with Low Debt
Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years
Annual Net Profits improving for last 2 years
Companies with Zero Promoter Pledge
Top Gainers
Stocks Outperforming their Industry Price Change in the Quarter
Ex-Date | Dividend Amount | Dividend Type | Record Date | Instrument Type |
|---|---|---|---|---|
| 11 Feb, 2026 | 12.7 | INTERIM | 11 Feb, 2026 | Equity Share |
| 30 Jul, 2025 | 7 | FINAL | 30 Jul, 2025 | Equity Share |
| 07 Feb, 2025 | 8.5 | INTERIM | 08 Feb, 2025 | Equity Share |
| 14 Aug, 2024 | 6.75 | FINAL | 14 Aug, 2024 | Equity Share |
| 16 Feb, 2024 | 5.5 | INTERIM | 16 Feb, 2024 | Equity Share |
| 17 Aug, 2023 | 9.25 | FINAL | Equity Share | |
| 17 Feb, 2023 | 8.5 | INTERIM | 18 Feb, 2023 | Equity Share |
| 12 Aug, 2022 | 8 | FINAL | Equity Share | |
| 23 Feb, 2022 | 8.5 | INTERIM | 24 Feb, 2022 | Equity Share |
| 01 Sep, 2021 | 8 | FINAL | Equity Share |
Financials | ||||||
|---|---|---|---|---|---|---|
| Price (₹) | ₹720 | ₹975 | ₹1,604 | ₹2,053 | ₹1,745.10 | ₹1,081.95 |
| % Change | -0.03% | -0.32% | -0.06% | -0.06% | -0.23% | -0.16% |
| Revenue TTM (₹ Cr) | ₹1,996.59 | ₹2,169.86 | ₹8,850.08 | ₹13,914.08 | ₹6,112.77 | ₹6,721.63 |
| Net Profit TTM (₹ Cr) | ₹484.66 | ₹332.94 | ₹869.92 | ₹1,779.35 | ₹847.18 | ₹843.32 |
| PE TTM | 83.50 | 62.20 | 35.00 | 47.70 | 34.00 | 69.40 |
| 1 Year Return | 26.36 | 43.56 | 70.22 | -12.49 | 22.7 | 87.09 |
| ROCE | 26.88 | 12.51 | 20.80 | 13.27 | 11.43 | 11.82 |
Alkem Laboratories Ltd.
₹ 5385.00
+0.27%
Biocon Ltd.
₹ 345.95
+0.07%
Divi's Laboratories Ltd.
₹ 5955.50
+0.05%
Ajanta Pharma Ltd.
₹ 2750.00
-0.04%
Glenmark Pharmaceuticals Ltd.
₹ 2161.80
-0.34%
Wockhardt Ltd.
₹ 1365.00
-0.34%
Aurobindo Pharma Ltd.
₹ 1339.20
-0.09%
Natco Pharma Ltd.
₹ 1127.00
+0.29%
Sun Pharmaceutical Industries Ltd.
₹ 1715.00
-0.12%
Ipca Laboratories Ltd.
₹ 1450.00
+0.01%
AstraZeneca Pharma India Ltd.
₹ 8050.00
-0.01%
GlaxoSmithKline Pharmaceuticals Ltd.
₹ 2357.00
-0.11%
Pfizer Ltd.
₹ 4735.00
-0.30%
Abbott India Ltd.
₹ 25765.00
-0.06%
Torrent Pharmaceuticals Ltd.
₹ 4090.00
-0.11%
Lupin Ltd.
₹ 2292.30
-0.12%
Dr. Reddy's Laboratories Ltd.
₹ 1211.00
-0.07%
Cipla Ltd.
₹ 1225.00
+0.05%
By signing up I certify terms, conditions & privacy policy